前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里






查看所有供应商和价格请点击:

53760-19-3生产厂家

53760-19-3价格

53760-19-3

53760-19-3结构式
53760-19-3结构式
  • 常用中文名:细胞松驰素 H
  • 常用英文名:Cytochalasin H
  • CAS号:53760-19-3
  • 分子式:C30H39NO5
  • 分子量:493.63
  • 相关类别: 原料药 抗生素类药物 其它抗生素类药
  • 发布时间:2018-07-01 19:11:10
  • 更新时间:2024-01-02 11:41:34
  • 细胞凝集素H是从真菌Phomopsis sp.中分离得到的天然产物。细胞凝集素H抑制细胞生长并诱导细胞凋亡。细胞松弛素H具有抗血管生成活性。细胞松弛素H是一种抗生素,具有抗菌活性[1][2][3]。

化源商城直购

中文名 细胞松弛素H
英文名 cytochalasin h
中文别名 细胞松驰素 H
英文别名 <11>Cytochalasin
paspalin
19-triene-1-one
cytochalasin U
paspalinpi
Paspalin P1
cytochalasinhfromphomopsissp.
kodocytochalasin-1
描述 细胞凝集素H是从真菌Phomopsis sp.中分离得到的天然产物。细胞凝集素H抑制细胞生长并诱导细胞凋亡。细胞松弛素H具有抗血管生成活性。细胞松弛素H是一种抗生素,具有抗菌活性[1][2][3]。
相关类别
体外研究 细胞松弛素H(24-72小时)抑制 A549细胞的增殖,IC50值为 159.5µM[1]细胞松弛素H(0-50µM;48小时)在 A549细胞中诱导细胞凋亡,使细胞周期停滞在 G2/M期,并影响细胞凋亡相关蛋白的表达[1] 细胞松弛素H(1-512μg/mL)对 多学科研究肠道致病菌、革兰氏阳性菌和金黄色葡萄球菌具有抗菌活性[3] 细胞凋亡分析[1]细胞系:A549细胞浓度:0、6.25、12.5、25和50µM培养时间:48小时结果:以剂量依赖性方式诱导A549细胞凋亡。细胞周期分析[1]细胞系:A549细胞浓度:0、6.25、12.5、25和50µM培养时间:48小时结果:细胞周期停滞在G2/M期和亚G1期峰值。Western Blot分析[1]细胞系:A549细胞浓度:0、6.25、12.5、25和50µM孵育时间:48小时结果:增加Bax、P53和裂解的胱天蛋白酶3的蛋白表达水平,降低Bcl-xL、Bcl-2和全长胱天蛋白酶-3的蛋白表达量。
体内研究 细胞松弛素H(2.5 mg/kg;腹腔注射)可以延迟 余额/cnu/nu小鼠中 A549异种移植肿瘤的生长[2] 动物模型:雄性Balb/cnu/nu小鼠A549异种移植物[2]剂量:2.5 mg/kg给药:腹腔注射;3次注射/周,持续80天结果:体内肿瘤生长减弱。
参考文献

[1]. Ma Y, et, al. Cytochalasin H isolated from mangrove‑derived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells. Oncol Rep. 2018 Jun;39(6):2899-2905.  

[2]. Yi JM, et, al. In Vivo Anti-tumor Effects of the Ethanol Extract of Gleditsia sinensis Thorns and Its Active Constituent, Cytochalasin H. Biol Pharm Bull. 2015;38(6):909-12.  

[3]. Jouda JB, et, al. Antibacterial and cytotoxic cytochalasins from the endophytic fungus Phomopsis sp. harbored in Garcinia kola (Heckel) nut. BMC Complement Altern Med. 2016 Nov 14;16(1):462.  

密度 1.19g/cm3
沸点 676.5ºC at 760mmHg
熔点 252-258ºC
分子式 C30H39NO5
分子量 493.63
闪点 362.9ºC
精确质量 493.28300
PSA 95.86000
LogP 4.06690
折射率 1.591
储存条件 2-8°C
水溶解性 chloroform: 10 mg/mL, clear, colorless

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: Cytochalasin H, from Phomopsis sp.
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 53760-19-3


SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Inhalation (Category 1), H330
Acute toxicity, Dermal (Category 2), H310
Acute toxicity, Oral (Category 2), H300
Reproductive toxicity (Category 2), H361
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
T+ Very toxicR26/27/28, R63
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal wordDanger
Hazard statement(s)
Fatal if swallowed.
Fatal in contact with skin.
Fatal if inhaled.
Suspected of damaging fertility or the unborn child.
Precautionary statement(s)
Do not breathe dust/ fume/ gas/ mist/ vapours/ spray.
Wash hands thoroughly after handling.
Wear protective gloves/ protective clothing.
Wear respiratory protection.
P302 + P350IF ON SKIN: Gently wash with plenty of soap and water.
Immediately call a POISON CENTER or doctor/ physician.
Supplemental Hazardnone
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Chemical characterization : Natural product
Formula: C30H39NO5
Molecular Weight: 493,63 g/mol
CAS-No.: 53760-19-3
Hazardous ingredients according to Regulation (EC) No 1272/2008
ComponentClassificationConcentration
Cytochalasin H from Phomopsis sp
CAS-No.53760-19-3Acute Tox. 1; Acute Tox. 2;<= 100 %
Repr. 2; H300, H310, H330,
Hazardous ingredients according to Directive 1999/45/EC
ComponentClassificationConcentration
Cytochalasin H from Phomopsis sp
CAS-No.53760-19-3T+, R26/27/28 - R63<= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
contact the supplier of the CE approved gloves. This recommendation is advisory only and must
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of
anticipated use by our customers. It should not be construed as offering an approval for any
specific use scenario.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: crystalline
Colour: white
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingMelting point/range: 254 - 258 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evapouration rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents, Strong bases
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
Human
lymphocyte
Cytogenetic analysis
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Suspected human reproductive toxicant
Overexposure may cause reproductive disorder(s) based on tests with laboratory animals.
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: HA5306000

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: 3462IMDG: 3462IATA: 3462
UN proper shipping name
ADR/RID: TOXINS EXTRACTED FROM LIVING SOURCES, SOLID, N.O.S. (Cytochalasin H from
Phomopsis sp)
IMDG: TOXINS, EXTRACTED FROM LIVING SOURCES, SOLID, N.O.S. (Cytochalasin H from
Phomopsis sp)
IATA:Toxins, extracted from living sources, solid, n.o.s. (Cytochalasin H from Phomopsis sp)
Transport hazard class(es)
ADR/RID: 6.1IMDG: 6.1IATA: 6.1
Packaging group
ADR/RID: IIIMDG: IIIATA: II
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HA5306000
CHEMICAL NAME :
(11)Cytochalasa-6(12),13,19-trien-1-one, 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10- phenyl-, (7S,13E,16S,18S,19E,21R)-
CAS REGISTRY NUMBER :
53760-19-3
LAST UPDATED :
199107
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C30-H39-N-O5
MOLECULAR WEIGHT :
493.70
WISWESSER LINE NOTATION :
T56-11- 1A R AXVM GY JU PUTJ D1R& F1 GU1 HQ M1 OQ O1 ROV1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
12500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
2341 ug/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - changes in motor activity (specific assay) Behavioral - ataxia

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
500 ug/L
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- Volume(issue)/page/year: 16,430,1978

符号 GHS06 GHS08
GHS06, GHS08
信号词 Danger
危害声明 H300-H310-H330-H361
警示性声明 P260-P264-P280-P284-P302 + P350-P310
个人防护装备 Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
危害码 (欧洲) T+
风险声明 (欧洲) 26/27/28-63
安全声明 (欧洲) 28-36/37-45
危险品运输编码 UN 3462 6.1/PG 2
WGK德国 3
RTECS号 HA5306000
包装等级 I
危险类别 6.1(a)